Trial intelligence / Profile preview

Anesthesia evaluation in patients undergoing cardiac surgery

RBR-8m444qNot yet recruiting

Sponsor
Universidade Federal do Rio Grande do Norte
Start
Mar 2012
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
Countries
1
01

Overview

Open-label trial of morphine, ropivacaine, propofol, sufentanil, pancuronium and 1 more in Chronic Coronary Syndrome (CCS) (2 arms), sponsored by Universidade Federal do Rio Grande do Norte. Planned start Mar 2012; status: not yet recruiting.

02

Drugs

morphineropivacainepropofolsufentanilpancuronium
03

Conditions

Chronic Coronary Syndrome (CCS)

Beyond the preview

Go deeper on RBR-8m444q.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on RBR-8m444q.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call